Das MedTech-Unternehmen Dermagnostix, Spezialist für vollautomatisierte Plug-and-Play Molekulardiagnostik in der Dermatologie, wird im Bereich der molekularen Diagnostik von Hauterkrankungen künftig mit Euroimmun, weltweit führender Anbieter…
18. December 2025
Dermagnostix announces the launch of the TargetDisk product line, expanding its portfolio with innovative molecular research tools designed for dermatological…
3. November 2025
This week, Vienna became the meeting point for pathologists from all over the world at the 37th European Congress of…
26. September 2025
Freiburg/Baden-Dättwil (CH), 1 September 2025 – Dermagnostix, specialized in the development of molecular diagnostic tests for dermatological issues, starts its distribution…
26. September 2025
Our CEO had the honor of being the special guest on the JuDerm podcast. In episode 13, they discussed the…
19. August 2025
Freiburg im Breisgau, 05.05.2025 – The Dermagnostix GmbH from Freiburg, specialized on the development of molecular diagnostic tests for dermatology,…
5. May 2025
Freiburg im Breisgau, 05.05.2025 – Die Dermagnostix GmbH aus Freiburg, spezialisiert auf die Entwicklung molekulardiagnostischer Tests für dermatologische Fragestellungen, erweitert…
5. May 2025
Dermagnostix CEO and Co-founder Prof. Dr. Natalie Garzorz Stark has been awared the Innovation Award Dermatology by Bundesverband der Deutschen…
22. March 2025
The President of the Baden-Württemberg Parliament, Muhterem Aras, and Nadyne Saint-Cast, Member of Parliament, recently visited Dermagnostix at its offices…
21. March 2025